Filing Flows › Comparisons › INFU vs BBNX
InfuSystem Holdings vs Beta Bionics: INFU and BBNX compared
InfuSystem Holdings is the larger company: $37.6M of revenue in its latest quarter (Q3 2026) against $35.5M for Beta Bionics (Q3 2026). Beta Bionics is growing faster (+30% against +3% a year earlier). InfuSystem Holdings is more profitable, with an operating margin of 12.6% against -74.9%.
Where the money goes: INFU and BBNX
InfuSystem Holdings (INFU) · Q3 2026
InfuSystem Holdings, Q3 2026: revenue $37.6M (+3% year over year), operating margin 12.6%, net earnings $3.2M, operating cash flow $10.3M. The chart follows the revenue to costs, profit and cash.
Beta Bionics (BBNX) · Q3 2026
Beta Bionics, Q3 2026: revenue $35.5M (+30% year over year), operating margin -74.9%, net loss $24.4M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
| InfuSystem Holdings (INFU) | Beta Bionics (BBNX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $37.6M | $35.5M |
| Revenue growth, Y/Y | +3% | +30% |
| Gross margin | 57.8% | — |
| Operating margin | 12.6% | -74.9% |
| Net earnings | $3.2M | −$24.4M |
| Net margin | 8.4% | -68.6% |
| Operating cash flow | $10.3M | −$12.3M |
| Free cash flow | $10.3M | — |
Where the revenue comes from
InfuSystem Holdings
- Patient Services: $25.8M (69%)
- Device Solutions: $11.8M (31%)
Questions
Which is bigger, InfuSystem Holdings or Beta Bionics?
InfuSystem Holdings is the larger company: $37.6M of revenue in its latest quarter (Q3 2026) against $35.5M for Beta Bionics (Q3 2026).
Is InfuSystem Holdings or Beta Bionics growing faster?
Beta Bionics is growing faster (+30% against +3% a year earlier).
Which is more profitable, InfuSystem Holdings or Beta Bionics?
InfuSystem Holdings is more profitable, with an operating margin of 12.6% against -74.9%.
More: InfuSystem Holdings earnings · how InfuSystem Holdings makes money · Beta Bionics earnings · how Beta Bionics makes money
From the companies' latest 10-Q, 10-K or earnings release (8-K filed Nov 5, 2026; 10-Q filed Oct 27, 2026). Fiscal quarters can end on different dates. Not investment advice.